WednesdayFeb 15, 2017 1:45 pm

22nd Century (NYSE: XXII) Starts Presentation at 2017 Disruptive Growth & Healthcare Conference

22nd Century (NYSE: XXII) is a plant biotech company providing technology that allows for the level of nicotine and other nicotinic alkaloids in tobacco plants and the level of cannabinoids in cannabis plants to be decreased or increased through genetic engineering and plant breeding. The company develops smoking cessation products and modified risk tobacco products for smokers who are unable or unwilling to quit smoking and who may be interested in cigarettes, which reduce exposure to nicotine or to certain tobacco smoke toxins and/or pose a lower health risk than conventional cigarettes. For more information, visit the company's website at…

Continue Reading

WednesdayFeb 15, 2017 8:30 am

Marijuana Industry Acquisitions on the Rise as Companies to Diversify Portfolios, Increase Revenue Streams

The global marijuana industry continues to develop at an impressive pace, driven by new developments in the field of cannabis-based pharmaceutics as well as the legalization of both medicinal and recreational use in a growing number of states. As a result, M&A activity in the market is heading toward exponential growth as well. Acquisitions help public companies diversify their portfolios and revenue streams while providing private companies access to more financing. Public companies such as SinglePoint, Inc. (SING) (SING Profile), Vinergy Resources Ltd. (VNNYF) and ChineseInvestors.com, Inc. (CIIX) have already initiated or completed such acquisitions, encouraged by the significant growth…

Continue Reading

TuesdayFeb 14, 2017 1:22 pm

Singlepoint, Inc. (SING) Helping Cannabis Businesses Accept Transactions in a Secure and Legal Way

Despite a total of 28 states having now legalized marijuana in some form, the U.S Drug Enforcement Administration still classifies cannabis as a Schedule 1 substance, alongside heroin and LSD. With this mind, it has been hard for the banking industry to support legal marijuana businesses. Because such businesses have fewer options in opening bank accounts with national banks, they are pressured to accept cash payments, making them vulnerable to all of the issues associated with operating a cash business. Cash transactions make cannabis businesses prime targets for theft and break-ins, not to mention the gap left open for certain…

Continue Reading

ThursdayFeb 09, 2017 9:13 am

ChineseInvestors.com, Inc. (CIIX) Aiming to Help Tackle Epilepsy with a CBD Oil-Based Pharmaceutical

ChineseInvestors.com, Inc. (OTCQB: CIIX), a company in the business of providing Chinese-speaking investors with real-time market analysis, commentary, and educational services, recently announced its goals for 2017, stating that it plans to develop a CBD oil-based pharmaceutical that could help with the major problem of epilepsy in China. CBD, also known as cannabidiol, is one of the most important healing substances in the hemp plant, helping treat inflammation, convulsions, insomnia, anxiety, ulcers, neuropathic pain, and epilepsy, among other medical problems. The difference between CBD and THC is that THC is classified as a federally controlled psychotropic drug, whereas CBD is…

Continue Reading

WednesdayFeb 08, 2017 8:30 am

Israeli Innovation is at the Heart of a Growing Cannabis Ecosystem

In a move that will certainly have an effect on both domestic and foreign cannabis companies such as Singlepoint Inc. (SING) (SING Profile), Rocky Mountain High (RMHB), mCig, Inc. (MCIG), General Cannabis Corp. (CANN) and Cannabics Pharmaceuticals, Inc. (CNBX), Israel is reportedly making strides toward allowing the export of medical marijuana, according to Reuters (1). The Israelis are widely regarded as leaders in medical marijuana research. However, the local market is small, estimated at $20 million, tops. Nevertheless, the meager market size appears to discourage neither innovation nor investment. As such, Israeli companies are involved in the value chain at…

Continue Reading

ThursdayFeb 02, 2017 9:19 am

ChineseInvestors.com, Inc. (CIIX) Revenues Rise For Quarter, Six Months Ended November 30, 2016

ChineseInvestors.com, Inc. (OTCQB: CIIX) filed form 10Q with the SEC on January 23, 2017, stating that it had sharply higher revenues in both the quarter and six months ended November 30, 2016, as compared to the same periods of the prior year. In this filing for its second quarter in fiscal year 2017, it also revised its financials for the year ended May 31, 2016, terming that refiling an immaterial correction. The company reported revenues of $510,944 for the three months ended November 30, 2016. That marked a 133% jump compared to revenues of $219,263 for the same period of…

Continue Reading

WednesdayFeb 01, 2017 10:08 am

Marijuana Industry Pushing Toward Federal Acceptance, Expanded Research in 2017

For the marijuana industry, 2016 was a successful year by any standards, reaching an estimated $7 billion in transactions and bringing the total number of states to legalize marijuana for medical and/or recreational purposes to 28. However, deemed America's fastest growing industry in recent years, the market still has some major obstacles to overcome in 2017, such as gaining access to legal banking services, obtaining federal drug reclassification, and more. Removing marijuana from the federal list of Schedule I drugs would be a major step forward for the industry, with massive implications and benefits trickling through to reach cannabis-related product…

Continue Reading

WednesdayFeb 01, 2017 9:16 am

ChineseInvestors.com, Inc. (CIIX) Discusses Recent Achievements Driving Aggressive Plans for 2017

On Monday, January 30, 2017, Alan Klitenic, the Director of Investor Relations for ChineseInvestors.com, Inc. (OTCQB: CIIX), was interviewed by CBDWire. Mr. Klitenic described the company, and the growing underserved market it has managed to successfully tap, some of the company’s achievements over the past year, and the aggressive goals it is already pursuing for 2017. Salient points include the following: Description - ChineseInvestors.com, Inc. is a unique financial media service that is tailored to the ethnic Chinese speaking population in the U.S. and Canada. Founded by long-time financial professional Warren Wang, it’s an American company, but with a strong…

Continue Reading

MondayJan 30, 2017 4:00 pm

CV Sciences, Inc. (CVSI) Starts Presentation at NobleCon13

CV Sciences (OTC: CVSI) focuses on developing and commercializing novel therapeutics utilizing synthetic Cannabidiol (CBD). The company operates through two segments, Specialty Pharmaceutical and Consumer Product. It also manufactures, markets and sells plant-based CBD products under PlusCBD brand for a range of market sectors, including nutraceutical, beauty care, specialty foods and vape. The company’s Pharmaceutical Division is developing synthetically formulated cannabidiol‐based medicine, pursuing the approval of the U.S. Food and Drug Administration (FDA) for drugs with specific indications utilizing cannabidiol as the active pharmaceutical ingredient. CV Sciences has achieved promising preclinical results in the development of cannabinoid medicines for treatment of…

Continue Reading

MondayJan 30, 2017 3:30 pm

MassRoots, Inc. (MSRT) Starts Presentation at NobleCon13

MassRoots (OTC: MSRT) operates a technology platform for the cannabis community in the United States. The company’s mobile network enables users to share cannabis content to connect with the legalization movement. Its network is accessible as a free mobile application through the iOS App Store and the Google Play marketplace. The company also operates MassRoots.com/shop, an e-commerce platform that allows visitors to order MassRoots T-shirts, jars and stickers, as well as MassRoots for Business, a free online portal for dispensaries to schedule posts, view analytics and gain insights into followers. For more information, visit the company’s website at www.massroots.com. About…

Continue Reading

CBDWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722